Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Mondello, Patrizia, Tadros Saber, Teater Matt, Fontan Lorena, Chang Aaron Y., Jain Neeraj, Yang Haopeng, Singh Shailbala, Ying Hsia-Yuan, Chu Chi-Shuen, et al.
, Cancer Discov, 2020 Mar, Volume 10, Issue 3, p.440-459, (2020)
Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.
Li, Meng, Chiang Ying-Ling, Lyssiotis Costas A., Teater Matthew R., Hong Jun Young, Shen Hao, Wang Ling, Hu Jing, Jing Hui, Chen Zhengming, et al.
, Cancer Cell, 2019 Jun 10, Volume 35, Issue 6, p.916-931.e9, (2019)